Posted On: 12/10/2013 3:24:40 PM
Post# of 144833
$VIVO Headlines
Meridian Bioscience sees strong fiscal 2013 8:40 a.m. Aug. 28, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 3:57 p.m. July 21, 2011 - Sue Chang
Meridian Bioscience tumbles 16% on forecast 11:26 a.m. July 21, 2011 - Val Brickates Kennedy
Meridian Bioscience slides 11% on forecast 8:50 a.m. July 21, 2011 - Val Brickates Kennedy
A defensive approach to a seasonally weak month 11:01 p.m. Aug. 31, 2009 - Michael Ashbaugh
Nasdaq hits the year's best levels 9:19 a.m. Aug. 28, 2009 - Michael Ashbaugh
Meridian Biosciences names William Motto executive chairman 4:03 p.m. Jan. 28, 2008 - Carla Mozee
Meridian Biosciences promotes John Kraeutler to CEO 4:02 p.m. Jan. 28, 2008 - Carla Mozee
U.S. markets signaling potential capitulation 2:42 p.m. Jan. 22, 2008 - Michael Ashbaugh
Bearish sentiment spikes, S&P 500 seeks a floor 11:07 a.m. Jan. 22, 2008 - Michael Ashbaugh
A corrective bounce, or sustainable upturn? 9:48 a.m. Jan. 14, 2008 - Michael Ashbaugh
Meridian: new flu tests expected to improve profitability 12:32 p.m. Nov. 26, 2007 - Wallace Witkowski
CORRECT: Rebound makes Navellier a happy camper 10:38 a.m. Oct. 30, 2007 - Peter Brimelow
Updates, advisories and surprises 6:01 p.m. Aug. 14, 2007 - MarketWatch
Meridian Bioscience backs 2007 outlook, issues 2008 view 12:33 p.m. Aug. 14, 2007 - Katherine Hunt
Meridian Bioscience sees FY08 rev $140M-$142M 12:21 p.m. Aug. 14, 2007 - Katherine Hunt
Meridian Bioscience reaffirms FY07 outlook 12:21 p.m. Aug. 14, 2007 - Katherine Hunt
U.S. markets pull in for third test of major support 8:47 a.m. Aug. 10, 2007 - Michael Ashbaugh
Meridian Bioscience ups fiscal 2007 outlook 11:24 a.m. June 5, 2007 - Gabriel Madway
Meridian Bioscience ups FY07 EPS view to 57c-60c 10:52 a.m. June 5, 2007 - Gabriel Madway
10-K: MERIDIAN BIOSCIENCE INC 9:36 a.m. Nov. 29, 2013 - Edgar Online - (EDG = 10Q, 10K)
VIVO Breaks Above 3% Yield Territory 3:11 p.m. Nov. 13, 2013 - TheStreet.com
VIVO Misses on Earnings, Revs In Line - Analyst Blog 9:40 a.m. Nov. 12, 2013 - Zacks.com
4 Healthcare Sector Dogs Hype 13% To 17% October Upsides; 4% To 7.5% Downsides 7:02 p.m. Nov. 8, 2013 - Seeking Alpha
8 Drug And Device 9% To 21% September Upsides Paced Healthcare Dogs 2:00 p.m. Oct. 9, 2013 - Seeking Alpha
Will These High-Yield Low-Risk Winners Fit In Your Portfolio? 9:39 a.m. Sept. 23, 2013 - Seeking Alpha
Sanofi 17.7% July/August Upside Again Led Healthcare Dogs 7:57 a.m. Aug. 22, 2013 - Seeking Alpha
10-Q: MERIDIAN BIOSCIENCE INC 8:34 a.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Meridian Life Science® Successfully Manufactures Influenza Challenge Stock for Immune Targeting Systems 5:00 a.m. July 30, 2013 - benzinga.com
68 Top Dividend Stocks with Ex-Dividend Date in August 2013 11:22 a.m. July 29, 2013 - GuruFocus.com
10 Top Healthcare Dogs Offer 4.5% To 15.4% June Upsides 9:31 a.m. July 17, 2013 - Seeking Alpha
UPDATE: Cowen and Company Downgrades Meridian Bioscience on Tough Road Ahead 9:25 a.m. July 16, 2013 - benzinga.com
Sanofi's 31% Upside Leads Healthcare Sector Dogs In June 10:35 a.m. July 8, 2013 - Seeking Alpha
Trinity Biotech: One Of The Most Inexpensive Names In Med-Tech With Catalysts 6:00 a.m. June 27, 2013 - Seeking Alpha
UPDATE: Meridian Bioscience Receives FDA Clearance for New Molecular Amplification Test: illumigene Mycoplasma 8:31 a.m. June 10, 2013 - benzinga.com
My 3 Favorite Healthcare Dividend Stocks with Highest Float Short Ratio 11:27 a.m. June 3, 2013 - GuruFocus.com
10 Hot Healthcare Dogs Probe 6% To 38.2% Gains In April 1:43 p.m. May 13, 2013 - Seeking Alpha
10-Q: MERIDIAN BIOSCIENCE INC 8:31 a.m. May 10, 2013 - Edgar Online - (EDG = 10Q, 10K)
9 Top Healthcare Dogs Hunt 3.5% To 51.9% Gains In April 9:37 a.m. May 6, 2013 - Seeking Alpha
Meridian Bioscience Earnings: Here’s Why Investors Don’t Like These Results 12:07 p.m. April 25, 2013 - Wall St. Cheat Sheet
PCR from Whole Blood, Simplified 10:17 a.m. Nov. 14, 2013 - BusinessWire
Meridian Bioscience Reports Record Fourth Quarter and Full-Year Operating Results, Declares Regular Cash Dividend, Announces Increased Regular Cash Dividend Rate for Fiscal 2014, and Reaffirms Fiscal 2014 Guidance 7:30 a.m. Nov. 7, 2013 - BusinessWire
Meridian Life Science Awarded SBIR by Centers for Disease Control and Prevention to Develop Rotavirus Vaccine 8:30 a.m. Oct. 31, 2013 - BusinessWire
Meridian Bioscience Provides Sales and Earnings Guidance for Fiscal 2014 and Reaffirms Fiscal 2013 Guidance 9:00 a.m. Sept. 9, 2013 - BusinessWire
Nanosphere to Present Data on the Verigene(R) System at the 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 7:01 a.m. Aug. 22, 2013 - Marketwire
Meridian Life Science(R) Successfully Manufactures Influenza Challenge Stock for Immune Targeting Systems 6:00 a.m. July 30, 2013 - BusinessWire
Meridian Bioscience Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2013 Guidance 6:30 a.m. July 25, 2013 - BusinessWire
Bioline Launches the MyTaq(TM) Extract-PCR Kit, Single Tube Extraction of PCR-Ready DNA from Mammalian Tissues 6:00 a.m. July 2, 2013 - BusinessWire
Meridian Bioscience Receives FDA Clearance for New Molecular Amplification Test: illumigene(R) Mycoplasma 9:30 a.m. June 10, 2013 - BusinessWire
Meridian Bioscience Reports Second Quarter and Six Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2013 Guidance 6:15 a.m. April 25, 2013 - BusinessWire
Meridian Bioscience Recognized by Forbes as One of America's 100 Most Trustworthy Companies 10:00 a.m. March 28, 2013 - BusinessWire
Mediaplanet partners with USA TODAY to distribute a special section dedicated to new or hopeful parents and healthy bundles of joy! 7:37 a.m. March 22, 2013 - PR Newswire
Meridian Bioscience Announces illumigene(R) Group A Streptococcus and illumigene(R) Group B Streptococcus Tests Categorized "Moderate Complexity" by FDA 10:45 a.m. March 18, 2013 - BusinessWire
Bioline Launches ISOLATE II, a Precious Find for DNA and RNA Isolation 7:00 a.m. Feb. 6, 2013 - BusinessWire
Meridian Bioscience Reports First Quarter 2013 Operating Results and Reaffirms Fiscal 2013 Guidance 7:30 a.m. Jan. 23, 2013 - BusinessWire
Meridian Bioscience Successfully Completes Beta Trials for Two New illumigene(R) Tests 2:45 p.m. Dec. 13, 2012 - BusinessWire
Meridian Bioscience sees strong fiscal 2013 8:40 a.m. Aug. 28, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 3:57 p.m. July 21, 2011 - Sue Chang
Meridian Bioscience tumbles 16% on forecast 11:26 a.m. July 21, 2011 - Val Brickates Kennedy
Meridian Bioscience slides 11% on forecast 8:50 a.m. July 21, 2011 - Val Brickates Kennedy
A defensive approach to a seasonally weak month 11:01 p.m. Aug. 31, 2009 - Michael Ashbaugh
Nasdaq hits the year's best levels 9:19 a.m. Aug. 28, 2009 - Michael Ashbaugh
Meridian Biosciences names William Motto executive chairman 4:03 p.m. Jan. 28, 2008 - Carla Mozee
Meridian Biosciences promotes John Kraeutler to CEO 4:02 p.m. Jan. 28, 2008 - Carla Mozee
U.S. markets signaling potential capitulation 2:42 p.m. Jan. 22, 2008 - Michael Ashbaugh
Bearish sentiment spikes, S&P 500 seeks a floor 11:07 a.m. Jan. 22, 2008 - Michael Ashbaugh
A corrective bounce, or sustainable upturn? 9:48 a.m. Jan. 14, 2008 - Michael Ashbaugh
Meridian: new flu tests expected to improve profitability 12:32 p.m. Nov. 26, 2007 - Wallace Witkowski
CORRECT: Rebound makes Navellier a happy camper 10:38 a.m. Oct. 30, 2007 - Peter Brimelow
Updates, advisories and surprises 6:01 p.m. Aug. 14, 2007 - MarketWatch
Meridian Bioscience backs 2007 outlook, issues 2008 view 12:33 p.m. Aug. 14, 2007 - Katherine Hunt
Meridian Bioscience sees FY08 rev $140M-$142M 12:21 p.m. Aug. 14, 2007 - Katherine Hunt
Meridian Bioscience reaffirms FY07 outlook 12:21 p.m. Aug. 14, 2007 - Katherine Hunt
U.S. markets pull in for third test of major support 8:47 a.m. Aug. 10, 2007 - Michael Ashbaugh
Meridian Bioscience ups fiscal 2007 outlook 11:24 a.m. June 5, 2007 - Gabriel Madway
Meridian Bioscience ups FY07 EPS view to 57c-60c 10:52 a.m. June 5, 2007 - Gabriel Madway
10-K: MERIDIAN BIOSCIENCE INC 9:36 a.m. Nov. 29, 2013 - Edgar Online - (EDG = 10Q, 10K)
VIVO Breaks Above 3% Yield Territory 3:11 p.m. Nov. 13, 2013 - TheStreet.com
VIVO Misses on Earnings, Revs In Line - Analyst Blog 9:40 a.m. Nov. 12, 2013 - Zacks.com
4 Healthcare Sector Dogs Hype 13% To 17% October Upsides; 4% To 7.5% Downsides 7:02 p.m. Nov. 8, 2013 - Seeking Alpha
8 Drug And Device 9% To 21% September Upsides Paced Healthcare Dogs 2:00 p.m. Oct. 9, 2013 - Seeking Alpha
Will These High-Yield Low-Risk Winners Fit In Your Portfolio? 9:39 a.m. Sept. 23, 2013 - Seeking Alpha
Sanofi 17.7% July/August Upside Again Led Healthcare Dogs 7:57 a.m. Aug. 22, 2013 - Seeking Alpha
10-Q: MERIDIAN BIOSCIENCE INC 8:34 a.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Meridian Life Science® Successfully Manufactures Influenza Challenge Stock for Immune Targeting Systems 5:00 a.m. July 30, 2013 - benzinga.com
68 Top Dividend Stocks with Ex-Dividend Date in August 2013 11:22 a.m. July 29, 2013 - GuruFocus.com
10 Top Healthcare Dogs Offer 4.5% To 15.4% June Upsides 9:31 a.m. July 17, 2013 - Seeking Alpha
UPDATE: Cowen and Company Downgrades Meridian Bioscience on Tough Road Ahead 9:25 a.m. July 16, 2013 - benzinga.com
Sanofi's 31% Upside Leads Healthcare Sector Dogs In June 10:35 a.m. July 8, 2013 - Seeking Alpha
Trinity Biotech: One Of The Most Inexpensive Names In Med-Tech With Catalysts 6:00 a.m. June 27, 2013 - Seeking Alpha
UPDATE: Meridian Bioscience Receives FDA Clearance for New Molecular Amplification Test: illumigene Mycoplasma 8:31 a.m. June 10, 2013 - benzinga.com
My 3 Favorite Healthcare Dividend Stocks with Highest Float Short Ratio 11:27 a.m. June 3, 2013 - GuruFocus.com
10 Hot Healthcare Dogs Probe 6% To 38.2% Gains In April 1:43 p.m. May 13, 2013 - Seeking Alpha
10-Q: MERIDIAN BIOSCIENCE INC 8:31 a.m. May 10, 2013 - Edgar Online - (EDG = 10Q, 10K)
9 Top Healthcare Dogs Hunt 3.5% To 51.9% Gains In April 9:37 a.m. May 6, 2013 - Seeking Alpha
Meridian Bioscience Earnings: Here’s Why Investors Don’t Like These Results 12:07 p.m. April 25, 2013 - Wall St. Cheat Sheet
PCR from Whole Blood, Simplified 10:17 a.m. Nov. 14, 2013 - BusinessWire
Meridian Bioscience Reports Record Fourth Quarter and Full-Year Operating Results, Declares Regular Cash Dividend, Announces Increased Regular Cash Dividend Rate for Fiscal 2014, and Reaffirms Fiscal 2014 Guidance 7:30 a.m. Nov. 7, 2013 - BusinessWire
Meridian Life Science Awarded SBIR by Centers for Disease Control and Prevention to Develop Rotavirus Vaccine 8:30 a.m. Oct. 31, 2013 - BusinessWire
Meridian Bioscience Provides Sales and Earnings Guidance for Fiscal 2014 and Reaffirms Fiscal 2013 Guidance 9:00 a.m. Sept. 9, 2013 - BusinessWire
Nanosphere to Present Data on the Verigene(R) System at the 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 7:01 a.m. Aug. 22, 2013 - Marketwire
Meridian Life Science(R) Successfully Manufactures Influenza Challenge Stock for Immune Targeting Systems 6:00 a.m. July 30, 2013 - BusinessWire
Meridian Bioscience Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2013 Guidance 6:30 a.m. July 25, 2013 - BusinessWire
Bioline Launches the MyTaq(TM) Extract-PCR Kit, Single Tube Extraction of PCR-Ready DNA from Mammalian Tissues 6:00 a.m. July 2, 2013 - BusinessWire
Meridian Bioscience Receives FDA Clearance for New Molecular Amplification Test: illumigene(R) Mycoplasma 9:30 a.m. June 10, 2013 - BusinessWire
Meridian Bioscience Reports Second Quarter and Six Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2013 Guidance 6:15 a.m. April 25, 2013 - BusinessWire
Meridian Bioscience Recognized by Forbes as One of America's 100 Most Trustworthy Companies 10:00 a.m. March 28, 2013 - BusinessWire
Mediaplanet partners with USA TODAY to distribute a special section dedicated to new or hopeful parents and healthy bundles of joy! 7:37 a.m. March 22, 2013 - PR Newswire
Meridian Bioscience Announces illumigene(R) Group A Streptococcus and illumigene(R) Group B Streptococcus Tests Categorized "Moderate Complexity" by FDA 10:45 a.m. March 18, 2013 - BusinessWire
Bioline Launches ISOLATE II, a Precious Find for DNA and RNA Isolation 7:00 a.m. Feb. 6, 2013 - BusinessWire
Meridian Bioscience Reports First Quarter 2013 Operating Results and Reaffirms Fiscal 2013 Guidance 7:30 a.m. Jan. 23, 2013 - BusinessWire
Meridian Bioscience Successfully Completes Beta Trials for Two New illumigene(R) Tests 2:45 p.m. Dec. 13, 2012 - BusinessWire
(0)
(0)Scroll down for more posts ▼
